Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-catechin | multiple interactions | ISO | MRPL4 (Homo sapiens) | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of MRPL4 mRNA | CTD | PMID:24763279 | 1,2-dimethylhydrazine | increases expression | ISO | Mrpl4 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of MRPL4 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | increases expression | ISO | Mrpl4 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of MRPL4 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | multiple interactions | ISO | Mrpl4 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPL4 mRNA | CTD | PMID:17942748 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of MRPL4 mRNA | CTD | PMID:32145629 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Mrpl4 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPL4 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MRPL4 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MRPL4 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Mrpl4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of MRPL4 mRNA | CTD | PMID:21570461 and PMID:24680724 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Mrpl4 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of MRPL4 mRNA | CTD | PMID:20188158 | 4-amino-2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 4-amino-2 and 6-dinitrotoluene affects the expression of MRPL4 mRNA | CTD | PMID:21346803 | acrolein | multiple interactions | ISO | MRPL4 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MRPL4 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MRPL4 mRNA | CTD | PMID:32699268 | all-trans-retinoic acid | decreases expression | ISO | MRPL4 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of MRPL4 mRNA | CTD | PMID:33167477 | alpha-pinene | multiple interactions | ISO | MRPL4 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MRPL4 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MRPL4 mRNA | CTD | PMID:32699268 | beauvericin | decreases expression | ISO | MRPL4 (Homo sapiens) | 6480464 | beauvericin results in decreased expression of MRPL4 mRNA | CTD | PMID:29203277 | benzo[a]pyrene | affects methylation | ISO | MRPL4 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of MRPL4 3' UTR | CTD | PMID:27901495 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MRPL4 mRNA | CTD | PMID:25181051 and PMID:32145629 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of MRPL4 mRNA | CTD | PMID:30816183 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of MRPL4 gene | CTD | PMID:28505145 | butan-1-ol | multiple interactions | ISO | MRPL4 (Homo sapiens) | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MRPL4 mRNA | CTD | PMID:29432896 | caffeine | decreases phosphorylation | ISO | MRPL4 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of MRPL4 protein | CTD | PMID:35688186 | cisplatin | decreases expression | ISO | MRPL4 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of MRPL4 mRNA | CTD | PMID:27594783 | clofibrate | decreases expression | ISO | Mrpl4 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of MRPL4 mRNA | CTD | PMID:17585979 | clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MRPL4 mRNA | CTD | PMID:17602206 | copper atom | multiple interactions | ISO | MRPL4 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of MRPL4 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | MRPL4 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of MRPL4 mRNA | CTD | PMID:20971185 | copper(II) chloride | increases expression | ISO | MRPL4 (Homo sapiens) | 6480464 | cupric chloride results in increased expression of MRPL4 mRNA | CTD | PMID:17211630 | dorsomorphin | multiple interactions | ISO | MRPL4 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | elemental selenium | multiple interactions | ISO | MRPL4 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of MRPL4 mRNA | CTD | PMID:19244175 | elemental selenium | increases expression | ISO | MRPL4 (Homo sapiens) | 6480464 | Selenium results in increased expression of MRPL4 mRNA | CTD | PMID:19244175 | enzyme inhibitor | multiple interactions | ISO | MRPL4 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MRPL4 protein | CTD | PMID:23301498 | fenthion | increases expression | ISO | Mrpl4 (Mus musculus) | 6480464 | Fenthion results in increased expression of MRPL4 mRNA | CTD | PMID:34813904 | folic acid | increases expression | ISO | Mrpl4 (Mus musculus) | 6480464 | Folic Acid results in increased expression of MRPL4 mRNA | CTD | PMID:25629700 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of MRPL4 mRNA | CTD | PMID:22061828 | hydrogen peroxide | increases expression | ISO | MRPL4 (Homo sapiens) | 6480464 | Hydrogen Peroxide results in increased expression of MRPL4 mRNA | CTD | PMID:18951874 | hypochlorous acid | decreases expression | ISO | Mrpl4 (Mus musculus) | 6480464 | Hypochlorous Acid results in decreased expression of MRPL4 mRNA | CTD | PMID:19376150 | ivermectin | decreases expression | ISO | MRPL4 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of MRPL4 protein | CTD | PMID:32959892 | lipopolysaccharide | multiple interactions | ISO | MRPL4 (Homo sapiens) | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPL4 mRNA | CTD | PMID:31059760 | mercury dibromide | multiple interactions | ISO | MRPL4 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MRPL4 mRNA | CTD | PMID:27188386 | methidathion | increases expression | ISO | Mrpl4 (Mus musculus) | 6480464 | methidathion results in increased expression of MRPL4 mRNA | CTD | PMID:34813904 | methotrexate | decreases expression | ISO | MRPL4 (Homo sapiens) | 6480464 | Methotrexate results in decreased expression of MRPL4 mRNA | CTD | PMID:24449571 | methyl methanesulfonate | decreases expression | ISO | MRPL4 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of MRPL4 mRNA | CTD | PMID:23649840 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MRPL4 mRNA | CTD | PMID:17602206 | ozone | multiple interactions | ISO | MRPL4 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MRPL4 mRNA more ... | CTD | PMID:32699268 | paracetamol | decreases expression | ISO | MRPL4 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of MRPL4 mRNA | CTD | PMID:21420995 more ... | paracetamol | multiple interactions | ISO | MRPL4 (Homo sapiens) | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPL4 mRNA | CTD | PMID:31059760 | perfluorooctanoic acid | decreases expression | ISO | MRPL4 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of MRPL4 protein | CTD | PMID:26879310 | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of MRPL4 protein | CTD | PMID:34958885 | phenylmercury acetate | increases expression | ISO | MRPL4 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of MRPL4 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | MRPL4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MRPL4 mRNA | CTD | PMID:27188386 | resveratrol | increases expression | ISO | Mrpl4 (Mus musculus) | 6480464 | resveratrol results in increased expression of MRPL4 mRNA | CTD | PMID:22610192 | SB 431542 | multiple interactions | ISO | MRPL4 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | selenium atom | multiple interactions | ISO | MRPL4 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of MRPL4 mRNA | CTD | PMID:19244175 | selenium atom | increases expression | ISO | MRPL4 (Homo sapiens) | 6480464 | Selenium results in increased expression of MRPL4 mRNA | CTD | PMID:19244175 | sodium arsenite | increases expression | ISO | MRPL4 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of MRPL4 mRNA | CTD | PMID:34032870 | Soman | decreases expression | EXP | | 6480464 | Soman results in decreased expression of MRPL4 mRNA | CTD | PMID:19281266 | tetrachloroethene | decreases expression | ISO | Mrpl4 (Mus musculus) | 6480464 | Tetrachloroethylene results in decreased expression of MRPL4 mRNA | CTD | PMID:28973375 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of MRPL4 mRNA | CTD | PMID:34492290 | vitamin E | increases expression | ISO | MRPL4 (Homo sapiens) | 6480464 | Vitamin E results in increased expression of MRPL4 mRNA | CTD | PMID:19244175 | vitamin E | multiple interactions | ISO | MRPL4 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of MRPL4 mRNA | CTD | PMID:19244175 | |